Emergent BioSolutions Inc. is a leading biopharmaceutical company dedicated to one simple mission - to protect life. We develop, manufacture and commercialize immune related biologics, vaccines and biotherapeutics that assist the body’s immune system to prevent or treat infectious and other life threatening diseases. Our marketed product, BioThrax® (Anthrax Vaccine Adsorbed), is the only vaccine licensed by the U.S. Food and Drug Administration for the prevention of anthrax infection. Our product pipeline also includes: two "next generation" anthrax vaccines, two anthrax therapeutics (immunoglobulin and monoclonal), two botulinum vaccines and a botulinum therapeutic, an oral typhoid vaccine, a next generation tuberculosis vaccine, a hepatitis B immunotherapy, and a chlamydia vaccine.

www.emergentbiosolutions.com

©Copyright Phacilitate Limited 2009

Click here to download the last three North American Vaccine Forum Main Announcements

Over 50 sponsors and exhibitors participated in 2009, with the floorplan sold out!

Click here to find out how your company can participate.